Last reviewed · How we verify
NCT05049174
Nurse-led Smoking Cessation Program With Follow-up in Healthy Life Centres: a Randomized Clinical Trial
NA trial testing Nuse-led interview and referral to municipal healthy life-centres in Smoking Cessation in 221 participants. Status unknown.
30 April 2024
Quick facts
| Lead sponsor | Vestre Viken Hospital Trust |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | health services research |
| Enrollment | 221 |
| Start date | 1 November 2021 |
| Primary completion | 30 April 2024 |
| Estimated completion | 30 April 2024 |
| Sites | 3 locations across Norway |
Drugs / interventions tested
- Nuse-led interview and referral to municipal healthy life-centres
Conditions studied
- Smoking Cessation — all drugs for Smoking Cessation →
- Smoking Behaviors — all drugs for Smoking Behaviors →
- Nurse's Role — all drugs for Nurse's Role →
- Cardiovascular Diseases — all drugs for Cardiovascular Diseases →
Sponsor
Vestre Viken Hospital Trust
Who can join
18 and older, any sex, with Smoking Cessation or Smoking Behaviors. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A better understanding of how to incorporate effective smoking cessation measures into clinical practice is requested. In this is prospective, multi-center, randomized, open, blinded end-point (PROBE) trial, we assigned daily smokers hospitalized with an acute cardiac event 1:1 to an in-hospital nurse-led smoking cessation intervention with direct referral to further follow-up in the municipal healthy life-centres (intensive intervention) or to written information about smoking cessation and the municipal program (low-threshold intervention) . The primary outcome will be the smoking cessation rates between the groups at 6 months follow-up. Key secondary outcomes include a cost-effectiveness analysis of the intensive intervention and cessation rates at 3- and 12-months follow-up, the proportion who used nicotine replacement therapy and the proportion who attended the healthy-life center program between the two groups. We also assess effects of recurrent cardiovascular events and mortality after 12 months, two and five years follow-up. Exploratory analyses include new knowledge about the patient and system factors of importance for participation to healthy life-centers and for changes in smoking behaviour.
Publications & conference data
3 peer-reviewed publications reference this trial (live from Europe PMC):
-
A multi-component intervention increased access to smoking cessation treatment after hospitalization for atherosclerotic cardiovascular disease: a randomized trial.
Pleym K, Dammen T, Wedon-Fekjaer H, Husebye E, et al · · 2024 · cited 1× · PMID 38666249 · DOI 10.1093/ehjopen/oeae028 -
Clinical and psychosocial factors predicting persistent smoking in hospitalized patients with atherosclerotic vascular disease: A prespecified analysis of two randomized controlled trials.
Getz V, Pleym K, Dammen T, Husebye E, et al · · 2026 · PMID 41869372 · DOI 10.18332/tpc/217328 -
Motivational smoking cessation counselling and community-based follow-up after hospitalisation for vascular disease: A randomised controlled trial.
Pleym K, Sverre E, Weedon-Fekjær H, Kahlon MS, et al · · 2026 · PMID 41267561 · DOI 10.1111/add.70249
Verify or expand the search:
- PubMed search for NCT05049174
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Smoking Cessation
Currently open trials in the same condition.
- NCT07420621 — Preliminary Effectiveness of Enhanced Text Message + Incentives · NA · recruiting
- NCT07224087 — Development of a MHBC Intervention for Weight Loss and Smoking Cessation for Pre-Bariatric Surgery Patients · Phase 1 · recruiting
- NCT07331519 — Integrating Smoking Cessation With Low-dose CT-screening for Lung Cancer · NA · recruiting
- NCT07210567 — Mindfulness-based Ecological Momentary Intervention for Smoking Cessation Among Cancer Survivors · NA · recruiting
- NCT07129590 — Trauma-Informed Care for Smoking Cessation for Pregnancy · NA · recruiting
Other Vestre Viken Hospital Trust trials
Trials by the same sponsor.
- NCT07200713 — Effect Study of SMART Treatment for Youth · NA · not yet recruiting
- NCT06906419 — Arthroscopic Trochleaplasty in Chronic Relapsing Patellar Dislocations: A Follow-up Study · enrolling by invitation
- NCT06920654 — Stabilization of the Shoulder Joint Using a Latarjet-like Procedure. · enrolling by invitation
- NCT06738381 — Digital Secondary Prevention After Atherosclerotic Cardiovascular Disease · NA · recruiting
- NCT06912061 — A Needle Technique for Achilles Tendon Lengthening in Pediatric Patients: A Prospective Study on Efficacy, Safety, and F · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05049174 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vestre Viken Hospital Trust
- Last refreshed: 13 March 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05049174.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing